Suppr超能文献

联合绷带接触镜、口服尼麦角林和局部自体血清治疗严重神经源性角膜炎。

Concomitant Bandage Contact Lens, Oral Nicergoline, and Topical Autologous Serum for Severe Neurotrophic Keratitis.

机构信息

Department of Cornea, External Disease, and Refractive Surgery, Instituto de Oftalmología "Conde de Valenciana," Mexico City, Mexico.

出版信息

Eye Contact Lens. 2023 Mar 1;49(3):116-119. doi: 10.1097/ICL.0000000000000970. Epub 2023 Feb 7.

Abstract

BACKGROUND

To report the outcomes of using the combination of oral nicergoline, autologous serum, and contact lens to enhance corneal epithelization in neurotrophic keratitis and to discuss the clinical potential of this management.

METHODS

This was a prospective consecutive case series study of eight patients treated for neurotrophic keratitis at the "Conde de Valenciana" Institute of Ophthalmology. Oral nicergoline, autologous serum, and bandage contact lens were initiated at the same time, immediately after stage 3 diagnosis keratitis was confirmed clinically, and until corneal epithelialization was achieved or eminent corneal perforation was seen. In patients where diabetes was a cause, glycosylate hemoglobin was measured to asses metabolic control. Corneal esthesiometry and corrected distance visual acuity were assessed before and after treatment.

RESULTS

This study included eight eyes of eight patients (5 men [62.5%], average age 57±17.9 years). All patients completed at least 1 month of follow-up after nicergoline and contact lens suspension. Of the eight eyes, no one had positive culture growth and complete epithelial healing was achieved in all cases. Half of patients had diabetes and had a poor metabolic control. Corneal sensitivity improved in all eyes almost 2 centimeters in Cochet-Bonnet esthesiometry ( P= 0.01). In addition, final visual acuity gains were obtained ( P= 0.100).

CONCLUSIONS

The combination of oral nicergoline, autologous serum, and bandage contact lens simultaneously could be an alternative in the management of stage 3 neurotrophic keratitis when conventional medical treatment has no improvement of corneal epithelization.

摘要

背景

报告使用口服尼麦角林、自体血清和接触镜联合治疗神经营养性角膜炎以促进角膜上皮愈合的结果,并探讨该治疗方法的临床潜力。

方法

这是一项在“Conde de Valenciana”眼科研究所对 8 例神经营养性角膜炎患者进行的前瞻性连续病例系列研究。在临床确诊角膜炎进入 3 期后,同时开始使用尼麦角林口服、自体血清和绷带接触镜治疗,直至角膜上皮化或明显出现角膜穿孔。对于因糖尿病引起的患者,测量糖化血红蛋白以评估代谢控制情况。在治疗前后评估角膜知觉和矫正视力距离。

结果

本研究包括 8 例 8 只眼(5 例男性[62.5%],平均年龄 57±17.9 岁)。所有患者在尼麦角林和接触镜悬液治疗后至少完成 1 个月的随访。在 8 只眼中,没有一只出现阳性培养生长,所有病例均完全愈合上皮。半数患者患有糖尿病且代谢控制不佳。角膜感觉在 Cochet-Bonnet 知觉测量中几乎所有眼睛都提高了近 2 厘米(P=0.01)。此外,还获得了最终的视力提高(P=0.100)。

结论

在常规药物治疗未能改善角膜上皮化的情况下,尼麦角林口服、自体血清和绷带接触镜联合治疗可能是 3 期神经营养性角膜炎治疗的一种替代方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验